# Genesis Capital: portfolio, investments and team > Genesis Capital is a private equity based in United States. 2 investments on record, latest Aug 2011. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/genesis-capital-8 (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Genesis Capital Last cheque observed Aug 2011. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet New fund $566M, Aug 2018 Private equity Series B Venture Cyber Security Network Security Cheques on record **0%** of best year **0** **cheques in 12 months**, 2 on record Since the last cheque **5537** days **00** hrs **00** min **00** sec Median round **$8.4M** Rounds led **0 of 2** Sole investor **1 rounds** Exits **1 from the portfolio** Pitch Genesis Capital ## Genesis Capital highlights - 01 2 rounds on record - 02 Mostly Series B and Venture: 100% of its rounds - 03 Sole investor in 1 rounds, median $1.8M - 04 1 exits from the portfolio ## What they do - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Cyber Security Network Security - **Based in:** Atlanta, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **2 appearances** - **2011** 1 round - **Aug** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Series B · US · afnm.com **$15M** With 2 others - **2006** 1 round - **Mar** **[ETARGET](https://millionrounds.com/company/etarget)** Venture · CZ · etargetnet.com **$1.8M** Sole investor An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **17 named** AD **Allan Drazen** PRESIDENT OF GENESIS CAPITAL PARTNERS, INC., MANAGER i Filing they signed AS **Andrew Smith** Executive Officer, Director i Filing they signed BL **Brian Laibow** Executive Committee member i Filing they signed BF **Brittany Fairweather** Executive Officer i Filing they signed CA **Charles August Jerabek** Executive Officer, Promoter i Filing they signed EK **Eli Kent** Member of the Manager's Manager Board i Filing they signed ES **Emily Stephens** Director i Filing they signed JK **Jason Keller** Director i Filing they signed JA **John August Canty** Executive Officer, Promoter i Filing they signed NS **Norma Smith** Director i Filing they signed RD **Robert DeFranco** Principal and the Chief Investment Officer and Chief Risk Officer of the Issuer's Manager and a member of the Manager's Manager Board i Filing they signed RW **Robert Wasmund** Executive Officer, Director i Filing they signed TC **Thomas Crone** Executive Officer i Filing they signed TW **Trixy Weiss** VICE PRESIDENT OF GENESIS CAPITAL PARTNERS, INC., MANAGER i Filing they signed WA **William August Bischoff** Executive Officer, Promoter i Filing they signed WM **William Moody** Member of the Manager's Manager Board i Filing they signed ZP **Zhijian Peng** Director i Filing they signed We also hold **21** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## Exits from the portfolio Companies it backed that were later bought or listed **1 in all** **[Affinium Pharmaceuticals](https://millionrounds.com/company/affinium-pharmaceuticals)** Bought by [Debiopharm Group](https://millionrounds.com/fund/debiopharm-innovat) **Undisclosed** Feb 2014 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$566M** raised in Aug 2018 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series B Venture Median round joined **$8.4M** the round, not its cheque Alone, median **$1.8M** Led 0 of 2 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Aug 2011 - **Exits:** 1 from the portfolio Rounds by stage said on their site - Series B *1* - Venture *1* Cheques by year Led Joined 2006 2011 **Pitching Genesis Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Quick answers about Genesis Capital ### What does Genesis Capital invest in? Genesis Capital invests most often at Series B and Venture (100% of the rounds on record), in sectors such as Cyber Security and Network Security. ### How active is Genesis Capital? 2 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2011. ### How big are Genesis Capital's cheques? The median round it joins is $8.4M. ### Is Genesis Capital investing now? No investments in the last 12 months; the latest was in Aug 2011. ### What kind of investor is Genesis Capital? Genesis Capital is a private equity firm based in Atlanta, United States. ### Has Genesis Capital raised a new fund? Its latest fund filing with the SEC was in Aug 2018, reporting $566M raised. ### When was Genesis Capital founded? Genesis Capital was founded in 2002. ### Where does this information on Genesis Capital come from? From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=genesis-capital-8) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=genesis-capital-8)